Screener
Janux Therapeutics JANX Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Janux Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:18 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338078
FAQ
- What is Janux Therapeutics's prepaid & other current?
- Janux Therapeutics (JANX) reported prepaid & other current of $12.28M in Q2 2026.
- How has Janux Therapeutics's prepaid & other current changed year-over-year?
- Janux Therapeutics's prepaid & other current increased by 28.6% year-over-year, from $9.54M to $12.28M.
- What is the long-term trend for Janux Therapeutics's prepaid & other current?
- Over 4 years (2021 to 2025), Janux Therapeutics's prepaid & other current has grown at a 56.5% compound annual growth rate (CAGR), from $6.19M to $37.15M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Janux Therapeutics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude